&lt;Advanced Viral Research Corp> said its facility to manufacture reticulose, an anti-viral agent, is ready for FDA inspection.    The company said it will make a formal request for thereview by the end of March.    The company said if the facility is approved, initial testsand trials on AIDS patients will start soon afterward. Reuter&#3;